Funding for this research was provided by:
American Heart Association (16GRNT29980001)
National Institutes of Health (HL111552, GM114359)
Received: 9 July 2018
Accepted: 22 October 2018
First Online: 6 November 2018
Ethics approval and consent to participate
: All experiments were conducted with the approval of the Institutional Animal Care and Use Committee of Temple University School of Medicine.The use of human subjects adhered to National Institutes of Health guidelines and was approved by the Institutional Review Board at Temple University School of Medicine. Written informed consent was obtained from all participants.
: Not applicable.
: L.E.K. is listed as an inventor on US Patent #8,470,766, entitled “Novel Protein Kinase C Therapy for the Treatment of Acute Lung Injury,” which is assigned to the Children’s Hospital of Philadelphia and the University of Pennsylvania.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.